tiprankstipranks
Artiva Biotherapeutics, Inc. (ARTV)
NASDAQ:ARTV
US Market
ARTV
Artiva Biotherapeutics, Inc.
RESEARCH TOOLSreports
Want to see ARTV full AI Analyst Report?

Artiva Biotherapeutics, Inc. (ARTV) Financial Statements

462 Followers

Artiva Biotherapeutics, Inc. Financial Overview

Artiva Biotherapeutics, Inc.'s market cap is currently $265.70M. The company's EPS TTM is $-0.85; its P/E ratio is -1.25; Artiva Biotherapeutics, Inc. is scheduled to report earnings on March 10, 2026, and the estimated EPS forecast is $-0.87. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 251.00K$ 33.49M$ 4.93M$ 2.00M
Gross Profit$ -2.60M$ 251.00K$ 33.49M$ 4.93M$ 2.00M
Operating Income$ -90.61M$ -67.28M$ -30.67M$ -59.83M$ -53.27M
EBITDA$ -88.01M$ -64.85M$ -28.41M$ -58.67M$ -71.58M
Net Income$ -83.86M$ -58.49M$ -27.70M$ -58.39M$ -71.83M
Balance Sheet
Cash & Short-Term Investments$ 108.01M$ 185.43M$ 76.97M$ 102.53M$ 160.92M
Total Assets$ 130.94M$ 209.58M$ 105.11M$ 133.05M$ 169.93M
Total Debt$ 10.94M$ 14.35M$ 16.91M$ 19.45M$ 1.74M
Net Debt$ -15.76M$ -25.88M$ -36.59M$ -83.08M$ -159.18M
Total Liabilities$ 20.97M$ 22.94M$ 267.13M$ 273.75M$ 258.78M
Stockholders' Equity$ 109.97M$ 186.64M$ -162.01M$ -140.70M$ -88.86M
Cash Flow
Free Cash Flow$ -79.34M$ -55.67M$ -50.69M$ -57.13M$ -17.03M
Operating Cash Flow$ -76.75M$ -55.03M$ -47.43M$ -50.83M$ -15.30M
Investing Cash Flow$ 63.41M$ -120.46M$ -25.98M$ -6.30M$ -1.72M
Financing Cash Flow$ 9.00K$ 162.23M$ 24.39M$ -1.26M$ 152.75M
Currency in USD

Artiva Biotherapeutics, Inc. Earnings and Revenue History

Income Statement >

Artiva Biotherapeutics, Inc. Debt to Assets

Balance Sheet >

Artiva Biotherapeutics, Inc. Cash Flow

Cash Flow >

Artiva Biotherapeutics, Inc. Forecast EPS vs Actual EPS

Earnings >